21st Century Cures Act

Pharmalot

Pharmalot, Pharmalittle: Is the 21st Century Cures bill in doubt over drug prices?

By Ed Silverman

Lamar Alexander
Politics

Senate delays Cures bill, as window for major legislation narrows

By David Nather

Lamar Alexander
Politics

Landmark effort to speed drug approvals nears critical phase in Congress

By David Nather

Lamar Alexander
Politics

Republicans seize on reports critiquing FDA to push for agency reforms

By Sheila Kaplan

Lamar Alexander
The Pharmalot View

Why we shouldn’t trade a weakened FDA for more medical research funds

By Ed Silverman

Prescription
Exclusive

Public wary of faster approvals of new drugs, STAT-Harvard poll finds

By David Nather and Sheila Kaplan

Politics

Fight over NIH funding puts Senate medical innovation bills in jeopardy

By Sheila Kaplan

Lamar Alexander
Politics

With comprehensive legislation stalled, Senate panel clears 7 smaller biomed bills

By Sheila Kaplan

Lamar Alexander, Patty Murray
Politics

Partisan split threatens progress on bill to speed drug approvals

By Sheila Kaplan

Pharmalot

A case for taking risks on drugs for the dying

By Ed Silverman

Politics

Michael Milken, from junk bonds to legislative advocate

By Sheila Kaplan

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy